Stockreport

Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF US$0.78 loss per share (further deteriorated from US$0.36 loss in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue [Read more]